Creabilis Therapeutics Srl

CREABILIS therapeutics is a drug discovery and development biotech company, founded in May 2003 with the aim to discover, select, develop and bring to commercial fruition novel and highly innovative therapeutic agents.

After four years of intense research activity a considerable, competitive and diversified project/product portfolio has been generated. CREABILIS is today strongly committed to exploit the potential of its discovery assets and its "know how" in the fields of inflammation / immunology, kinase inhibition and cytokine networking, mainly in the area of "Skin Pathologies".

Although some of the products in development can have applications in other very promising clinical areas, the company, with its portfolio, has acquired a unique and distinguishable position in research and development of "ethical dermatology" drugs.